Study Summary
This trial tests a new cancer treatment to see if it's safe, tolerable, and effective against advanced tumors.
- Advanced Solid Tumors
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
4 Primary · 26 Secondary · Reporting Duration: Up to 3 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
LB101
1 of 1
Experimental Treatment
180 Total Participants · 1 Treatment Group
Primary Treatment: LB101 · No Placebo Group · Phase 1 & 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is enrollment for this research endeavor still open?
"According to clinicaltrials.gov, this trial is still actively searching for volunteers. The research was initially posted on March 28th 2023 and has undergone modifications as recently as April 6th of the same year." - Anonymous Online Contributor
What is the participant capacity for this trial?
"Affirmative. According to information hosted on clinicaltrials.gov, this medical trial is open for enrollment and was posted online on March 28th 2023 with the most recent update coming April 6th of that same year. Currently, 180 patients are being sought from one site." - Anonymous Online Contributor